We provide in vivo and in vitro evidence that the BACE1/APP ratio primarily determines BACE1-mediated Aβ clearance: In AD brain tissue, we found levels of both BACE1 and Aβ34 approximately two-fold elevated. This evidence concerns the gene APP and Alzheimer disease.